Hit and Lead Profiling: Identification and Optimization of Drug-like Molecules
Drug-drug interactions: Screening for liability and assessment of risk
Publication
, Chapter
Hyland, R; Obach, RS; Stoner, C; West, M; Wester, MR; Youdim, K; Zientek, M
March 2, 2010
Duke Scholars
DOI
ISBN
9783527323319
Publication Date
March 2, 2010
Volume
43
Start / End Page
165 / 196
Citation
APA
Chicago
ICMJE
MLA
NLM
Hyland, R., Obach, R. S., Stoner, C., West, M., Wester, M. R., Youdim, K., & Zientek, M. (2010). Drug-drug interactions: Screening for liability and assessment of risk. In Hit and Lead Profiling: Identification and Optimization of Drug-like Molecules (Vol. 43, pp. 165–196). https://doi.org/10.1002/9783527627448.ch8
Hyland, R., R. S. Obach, C. Stoner, M. West, M. R. Wester, K. Youdim, and M. Zientek. “Drug-drug interactions: Screening for liability and assessment of risk.” In Hit and Lead Profiling: Identification and Optimization of Drug-like Molecules, 43:165–96, 2010. https://doi.org/10.1002/9783527627448.ch8.
Hyland R, Obach RS, Stoner C, West M, Wester MR, Youdim K, et al. Drug-drug interactions: Screening for liability and assessment of risk. In: Hit and Lead Profiling: Identification and Optimization of Drug-like Molecules. 2010. p. 165–96.
Hyland, R., et al. “Drug-drug interactions: Screening for liability and assessment of risk.” Hit and Lead Profiling: Identification and Optimization of Drug-like Molecules, vol. 43, 2010, pp. 165–96. Scopus, doi:10.1002/9783527627448.ch8.
Hyland R, Obach RS, Stoner C, West M, Wester MR, Youdim K, Zientek M. Drug-drug interactions: Screening for liability and assessment of risk. Hit and Lead Profiling: Identification and Optimization of Drug-like Molecules. 2010. p. 165–196.
DOI
ISBN
9783527323319
Publication Date
March 2, 2010
Volume
43
Start / End Page
165 / 196